TUNG YANG GUANG PHARMACEUTICAL (06887.HK) 0.000 (0.000%) Short selling $5.58M; Ratio 38.989% announced that at the 2026 American Association for Cancer Research (AACR) Annual Meeting held from April 17 to 22 in San Diego, California, the United States, the group presented the latest preclinical research results of three oncology pipeline candidates in the form of three poster presentations. The projects cover a CDH17/4-1BB bispecific antibody, an oral highly active Pan-RAS molecular glue inhibitor, and an oral small-molecule PD-L1 inhibitor. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-01 16:25.)
AASTOCKS Financial News